As we continue to hear from individuals who have allegedly suffered side effects associated with the Stryker hip recall, we are excited to see this litigation moving forward.
New York, New York (PRWEB) March 29, 2013
Bernstein Liebhard LLP notes that the judge overseeing Stryker Rejuvenate lawsuits in a consolidated litigation currently underway in New Jersey’s Bergen County Superior Court has scheduled the litigation’s next case management conference for April 10 at 10 a.m., according to the calendar posted on the court’s website. Court records indicate there were 81 Stryker Rejuvenate lawsuits pending in the New Jersey litigation as of February 20. Claims filed in this litigation were brought on behalf of patients affected by Stryker Orthopaedics’ July 2012 recall of its Rejuvenate and ABG II Modular-Neck Hip Stems. (In re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
“As we continue to hear from individuals who have allegedly suffered side effects associated with the Stryker hip recall, we are excited to see this litigation moving forward. The New Jersey litigation is one of the first to handle this type of metal hip defect,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of dangerous drugs and medical devices, including patients who have filed lawsuits over the Stryker Rejuvenate modular-neck hip stem.
The Firm is currently offering free and confidential case evaluations of potential Stryker Rejuvenate lawsuits for patients who allegedly sustained injuries from the hip stems.
Stryker Rejuvenate Lawsuits
All of the Stryker Rejuvenate lawsuits now pending in the New Jersey litigation were filed on behalf of patients affected by the Stryker hip recall, which was announced by Stryker Orthopaedics on July 6, 2012. The recall was issued after data indicated the potential for the metal stems to fret and corrode at the modular neck junction. In the months following the recall, the company has advised that patients implanted with the hip’s recalled components undergo cross sectional imaging and metal ion testing, even if they are not experiencing pain or other symptoms of hip failure. The most recent recall update posted on Stryker’s website says that some patients who received the Stryker Rejuvenate have experienced adverse tissue reactions and/or high metal ion levels in their blood, even without experiencing any symptoms.*
Additionally, Stryker has partnered with third-party claims administrator, Broadspire Services Inc, to manage reimbursement requests from patients seeking compensation for out-of-pocket costs related to the Stryker Rejuvenate recall.** However, Bernstein Liebhard LLP is advising potential participants of the Broadspire Stryker claims program to seek legal advice before signing any paperwork. Any information disclosed in a Broadspire Stryker claim could be used later as evidence in a Stryker Rejuvenate lawsuit.
Meanwhile, plaintiffs in federally-filed Stryker Rejuvenate lawsuits have motioned to transfer all claims to the U.S. District Court, District of Minnesota. On March 18th, a Brief filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML) indicated that Defendants in Stryker Rejuvenate lawsuits have voiced support for the creation of a multidistrict litigation (MDL) for federally-filed claims at this location. (In Re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, Case Pending No. 20 (JPML))
Individuals who have suffered pain, metal ion poisoning, hip implant failures or revision surgery allegedly caused by the recalled Rejuvenate and ABG II components may be eligible to file a Stryker Rejuvenate lawsuit seeking compensation for their medical expenses, pain and suffering, and other damages. Stryker Rejuvenate recall information is available at Bernstein Liebhard LLP’s Stryker Hip Recall Information Center. Call for a free lawsuit evaluation at 877-779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #
Felecia L. Stern, Esq.
Bernstein Liebhard LLP